Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Sep, 2018 | Pages:
115 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
This report studies the global market size of Opioids in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioids in these regions. This research report categorizes the global Opioids market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. In 2017, the global Opioids market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Opioids market based on company, product type, application and key regions. The various contributors involved in the value chain of Opioids include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Opioids include • Pfizer Inc • Purdue Pharma • Boehringer Ingelheim • Janssen Pharmaceuticals • Actavis Plc • Sanofi • Sun Pharmaceutical Industries Ltd • Mallinckrodt Pharmaceuticals • Endo Pharmaceuticals Inc • Egalet Market Size Split by Type • Morphine • Codeine • Methadone • Meperidine • Fentanyl Market Size Split by Application • Anesthesia • Cough Suppressant • Diarrhea suppressant Market size split by Region • North America • United States • Canada • Mexico • Asia-Pacific • China • India • Japan • South Korea • Australia • Indonesia • Singapore • Malaysia • Philippines • Thailand • Vietnam • Europe • Germany • France • UK • Italy • Spain • Russia • Central & South America • Brazil • Rest of Central & South America • Middle East & Africa • GCC Countries • Turkey • Egypt • South Africa The study objectives of this report are: • To study and analyze the global Opioids market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. • To understand the structure of Opioids market by identifying its various subsegments. • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). • Focuses on the key global Opioids manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. • To analyze the Opioids with respect to individual growth trends, future prospects, and their contribution to the total market. • To project the value and volume of Opioids submarkets, with respect to key regions (along with their respective key countries). • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. • To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Opioids are as follows: • History Year: 2013-2017 • Base Year: 2017 • Estimated Year: 2018 • Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioids market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Opioids Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Opioids Market Size Growth Rate by Type
1.4.2 Morphine
1.4.3 Codeine
1.4.4 Methadone
1.4.5 Meperidine
1.4.6 Fentanyl
1.5 Market by Application
1.5.1 Global Opioids Market Size Growth Rate by Application
1.5.2 Anesthesia
1.5.3 Cough Suppressant
1.5.4 Diarrhea suppressant
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioids Market Size
2.1.1 Global Opioids Revenue 2016-2025
2.1.2 Global Opioids Sales 2016-2025
2.2 Opioids Growth Rate by Regions
2.2.1 Global Opioids Sales by Regions
2.2.2 Global Opioids Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Opioids Sales by Manufacturers
3.1.1 Opioids Sales by Manufacturers
3.1.2 Opioids Sales Market Share by Manufacturers
3.1.3 Global Opioids Market Concentration Ratio (CR5 and HHI)
3.2 Opioids Revenue by Manufacturers
3.2.1 Opioids Revenue by Manufacturers (2016-2018)
3.2.2 Opioids Revenue Share by Manufacturers (2016-2018)
3.3 Opioids Price by Manufacturers
3.4 Opioids Manufacturing Base Distribution, Product Types
3.4.1 Opioids Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioids Product Category
3.4.3 Date of International Manufacturers Enter into Opioids Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Opioids Sales by Type
4.2 Global Opioids Revenue by Type
4.3 Opioids Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Opioids Breakdown Data by Application
6 North America
6.1 North America Opioids by Countries
6.1.1 North America Opioids Sales by Countries
6.1.2 North America Opioids Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Opioids by Type
6.3 North America Opioids by Application
6.4 North America Opioids by Company
7 Europe
7.1 Europe Opioids by Countries
7.1.1 Europe Opioids Sales by Countries
7.1.2 Europe Opioids Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioids by Type
7.3 Europe Opioids by Application
7.4 Europe Opioids by Company
8 Asia Pacific
8.1 Asia Pacific Opioids by Countries
8.1.1 Asia Pacific Opioids Sales by Countries
8.1.2 Asia Pacific Opioids Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Opioids by Type
8.3 Asia Pacific Opioids by Application
8.4 Asia Pacific Opioids by Company
9 Central & South America
9.1 Central & South America Opioids by Countries
9.1.1 Central & South America Opioids Sales by Countries
9.1.2 Central & South America Opioids Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Opioids by Type
9.3 Central & South America Opioids by Application
9.4 Central & South America Opioids by Company
10 Middle East and Africa
10.1 Middle East and Africa Opioids by Countries
10.1.1 Middle East and Africa Opioids Sales by Countries
10.1.2 Middle East and Africa Opioids Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Opioids by Type
10.3 Middle East and Africa Opioids by Application
10.4 Middle East and Africa Opioids by Company
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Opioids
11.1.4 Opioids Product Description
11.1.5 Recent Development
11.2 Purdue Pharma
11.2.1 Purdue Pharma Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Opioids
11.2.4 Opioids Product Description
11.2.5 Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Opioids
11.3.4 Opioids Product Description
11.3.5 Recent Development
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Opioids
11.4.4 Opioids Product Description
11.4.5 Recent Development
11.5 Actavis Plc
11.5.1 Actavis Plc Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Opioids
11.5.4 Opioids Product Description
11.5.5 Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Opioids
11.6.4 Opioids Product Description
11.6.5 Recent Development
11.7 Sun Pharmaceutical Industries Ltd
11.7.1 Sun Pharmaceutical Industries Ltd Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Opioids
11.7.4 Opioids Product Description
11.7.5 Recent Development
11.8 Mallinckrodt Pharmaceuticals
11.8.1 Mallinckrodt Pharmaceuticals Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Opioids
11.8.4 Opioids Product Description
11.8.5 Recent Development
11.9 Endo Pharmaceuticals Inc
11.9.1 Endo Pharmaceuticals Inc Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Opioids
11.9.4 Opioids Product Description
11.9.5 Recent Development
11.10 Egalet
11.10.1 Egalet Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Opioids
11.10.4 Opioids Product Description
11.10.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Opioids Raw Material
13.1.2 Opioids Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Opioids
Figure Global Opioids Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Opioids Production Market Share by Types (Product Category) in 2017
Figure Morphine Product Picture
Table Major Manufacturers of Morphine
Figure Codeine Product Picture
Table Major Manufacturers of Codeine
Figure Methadone Product Picture
Table Major Manufacturers of Methadone
Figure Meperidine Product Picture
Table Major Manufacturers of Meperidine
Figure Fentanyl Product Picture
Table Major Manufacturers of Fentanyl
Table Global Opioids Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Anesthesia
Figure Cough Suppressant
Figure Diarrhea suppressant
Figure Opioids Report Years Considered
Figure Global Opioids Market Size 2016-2025 (Million US$)
Figure Global Opioids Sales 2016-2025 (K Units)
Table Global Opioids Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Opioids Sales by Regions 2016-2025 (K Units)
Table Global Opioids Sales Market Share by Regions 2016-2025
Figure Global Opioids Sales Market Share by Regions 2016-2025
Figure 2017 Global Opioids Sales Market Share by Regions
Table Global Opioids Revenue by Regions 2016-2025 (Million US$)
Table Global Opioids Revenue Market Share by Regions 2016-2025
Figure Global Opioids Revenue Market Share by Regions 2016-2025
Figure 2017 Global Opioids Revenue Market Share by Regions
Table Global Opioids Sales by Manufacturers (2016-2018) (K Units)
Table Global Opioids Sales Share by Manufacturers (2016-2018)
Figure Global Opioids Sales Share by Manufacturers in 2017
Table Opioids Revenue by Manufacturers (2016-2018) (Million US$)
Table Opioids Revenue Share by Manufacturers (2016-2018)
Figure Opioids Value Share by Manufacturers in 2017
Table Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Opioids Price (2016-2018) (USD/Unit)
Table Opioids Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Opioids Product Category
Table Date of International Manufacturers Enter into Opioids Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Opioids Sales by Type (2016-2025) (K Units)
Table Global Opioids Sales Share by Type (2016-2025)
Figure Global Opioids Sales Market Share by Type (2016-2025)
Figure Global Opioids Sales Market Share by Type in 2017
Table Global Opioids Revenue by Type (2016-2025) (Million US$)
Table Global Opioids Revenue Share by Type (2016-2025)
Figure Global Opioids Revenue Market Share by Type (2016-2025)
Figure Global Opioids Revenue Market Share by Type in 2017
Table Opioids Price by Type 2013-2018 (USD/Unit)
Table Global Opioids Sales by Application (2016-2025) (K Units)
Table Global Opioids Sales Share by Application (2016-2025)
Figure Global Sales Opioids Market Share by Application (2016-2025)
Figure Global Sales Opioids Market Share by Application (2016-2025)
Figure North America Opioids Sales Growth Rate 2016-2025 (K Units)
Figure North America Opioids Revenue Growth Rate 2016-2025 (Million US$)
Table North America Opioids Sales by Countries (2016-2025) (K Units)
Table North America Opioids Sales Market Share by Countries (2016-2025)
Figure 2017 North America Opioids Sales Market Share by Countries
Table North America Opioids Revenue by Countries (2016-2025) (Million US$)
Table North America Opioids Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Opioids Revenue Market Share by Countries
Figure United States Opioids Sales Growth Rate (2016-2025) (K Units)
Figure United States Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Canada Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Opioids Revenue Growth Rate (2016-2025) (Million US$)
Table North America Opioids Sales by Type (2016-2025) (K Units)
Table North America Opioids Sales Market Share by Type (2016-2025)
Figure 2017 North America Opioids Market Share by Type
Table North America Opioids Sales by Application (2016-2025) (K Units)
Table North America Opioids Sales Market Share by Application (2016-2025)
Figure 2017 North America Opioids Market Share by Application
Table North America Opioids Sales by Company (2016-2018) (K Units)
Table North America Opioids Sales Market Share by Company (2016-2018)
Figure North America Opioids Sales Market Share by Company in 2017
Figure Europe Opioids Sales Growth Rate 2016-2025 (K Units)
Figure Europe Opioids Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Opioids Sales by Countries (2016-2025) (K Units)
Table Europe Opioids Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Opioids Sales Market Share by Countries
Table Europe Opioids Revenue by Countries (2016-2025) (Million US$)
Table Europe Opioids Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Opioids Revenue Market Share by Countries
Figure Germany Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Germany Opioids Revenue Growth Rate (2016-2025) (K Units)
Figure France Opioids Sales Growth Rate (2016-2025) (K Units)
Figure France Opioids Revenue Growth Rate (2016-2025) (K Units)
Figure UK Opioids Sales Growth Rate (2016-2025) (K Units)
Figure UK Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Italy Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Russia Opioids Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Opioids Sales by Type (2016-2025) (K Units)
Table Europe Opioids Sales Market Share by Type (2016-2025)
Figure 2017 Europe Opioids Market Share by Type
Table Europe Opioids Sales by Application (2016-2025) (K Units)
Table Europe Opioids Sales Market Share by Application (2016-2025)
Figure 2017 Europe Opioids Market Share by Application
Table Europe Opioids Sales by Company (2016-2018) (K Units)
Table Europe Opioids Sales Market Share by Company (2016-2018)
Figure Europe Opioids Sales Market Share by Company in 2017
Figure Asia Pacific Opioids Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Opioids Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Opioids Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Opioids Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioids Sales Market Share by Countries
Table Asia Pacific Opioids Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Opioids Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioids Revenue Market Share by Countries
Figure China Opioids Sales Growth Rate (2016-2025) (K Units)
Figure China Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Japan Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Korea Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure India Opioids Sales Growth Rate (2016-2025) (K Units)
Figure India Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Australia Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Opioids Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Opioids Sales by Type (2016-2025) (K Units)
Table Asia Pacific Opioids Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Opioids Market Share by Type
Table Asia Pacific Opioids Sales by Application (2016-2025) (K Units)
Table Asia Pacific Opioids Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Opioids Market Share by Application
Table Asia Pacific Opioids Sales by Company (2016-2018) (K Units)
Table Asia Pacific Opioids Sales Market Share by Company (2016-2018)
Figure Asia Pacific Opioids Sales Market Share by Company in 2017
Figure Central & South America Opioids Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Opioids Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Opioids Sales by Countries (2016-2025) (K Units)
Table Central & South America Opioids Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioids Sales Market Share by Countries
Table Central & South America Opioids Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Opioids Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioids Revenue Market Share by Countries
Figure Brazil Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Opioids Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Opioids Sales by Type (2016-2025) (K Units)
Table Central & South America Opioids Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Opioids Market Share by Type
Table Central & South America Opioids Sales by Application (2016-2025) (K Units)
Table Central & South America Opioids Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Opioids Market Share by Application
Table Central & South America Opioids Sales by Company (2016-2018) (K Units)
Table Central & South America Opioids Sales Market Share by Company (2016-2018)
Figure Central & South America Opioids Sales Market Share by Company in 2017
Figure Middle East and Africa Opioids Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Opioids Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Opioids Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Opioids Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Opioids Sales Market Share by Countries
Table Middle East and Africa Opioids Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Opioids Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Opioids Revenue Market Share by Countries
Figure GCC Countries Opioids Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Opioids Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Opioids Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Opioids Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Opioids Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Opioids Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Opioids Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Opioids Market Share by Type
Table Middle East and Africa Opioids Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Opioids Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Opioids Market Share by Application
Table Middle East and Africa Opioids Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Opioids Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Opioids Sales Market Share by Company in 2017
Table Pfizer Inc Company Details
Table Pfizer Inc Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Inc Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Purdue Pharma Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Boehringer Ingelheim Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Janssen Pharmaceuticals Recent Development
Table Actavis Plc Company Details
Table Actavis Plc Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Actavis Plc Recent Development
Table Sanofi Company Details
Table Sanofi Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Sun Pharmaceutical Industries Ltd Company Details
Table Sun Pharmaceutical Industries Ltd Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sun Pharmaceutical Industries Ltd Recent Development
Table Mallinckrodt Pharmaceuticals Company Details
Table Mallinckrodt Pharmaceuticals Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mallinckrodt Pharmaceuticals Recent Development
Table Endo Pharmaceuticals Inc Company Details
Table Endo Pharmaceuticals Inc Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Endo Pharmaceuticals Inc Recent Development
Table Egalet Company Details
Table Egalet Opioids Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Egalet Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Opioids Value Chain
Table Typical Suppliers of Key Opioids Raw Material
Table Opioids Customers List
Table Opioids Sales Channels
Table Opioids Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources 
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
